SCHEMBL1721763

SCHEMBL1721763

COc1ccc(C(Sc2ccc(-c3cccc(N)n3)cc2)c2ccc(OC)cc2)cc1.COc1ccc(C(Sc2ccc(B(O)O)cc2)c2ccc(OC)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 2/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
DYRK1A Q13627 1/20 0.36
ASIC3 Q9UHC3 1/20 0.36
PARP1 P09874 1/20 0.35
JAK1 P23458 1/20 0.35
SERPINH1 P50454 1/20 0.35
NPC1 O15118 2/20 0.34
ALDH1A1 P00352 2/20 0.34
RAB9A P51151 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
MAPT P10636 2/20 0.34
POLB P06746 1/20 0.34
MPO P05164 1/20 0.34
KDM4E B2RXH2 2/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
CDK5 Q00535 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2033015 0.91 ASIC3 (0.43) DYRK1AASIC3PARP1SERPINH1NPC1
SCHEMBL1721764 0.84 MAPT (0.36) DYRK1ANPC1ALDH1A1RAB9ASMN1; SMN2
SCHEMBL1684444 0.81 CA2 (0.61) ENPP2CA1CA2SERPINH1NPC1
SCHEMBL8090460 0.76 ASIC3 (0.60) DYRK1AASIC3PARP1NPC1ALDH1A1
SCHEMBL14457583 0.71 CA1 (0.44) ENPP2CA1CA2SERPINH1NPC1
SCHEMBL3628069 0.65 NPC1 (0.61) DYRK1APARP1NPC1ALDH1A1RAB9A
SCHEMBL28832985 0.65 CA2 (0.86) ENPP2CA1CA2NPC1RAB9A
SCHEMBL257917 0.65 CA2 (0.86) ENPP2CA1CA2NPC1RAB9A
SCHEMBL1723482 0.65 ALDH1A1 (0.43) DYRK1AASIC3NPC1ALDH1A1RAB9A
SCHEMBL13235087 0.64 LTA4H (0.60) ALDH1A1SMN1; SMN2MAPTKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2395002-B1 PHARMACEUTICAL COMPOSITION CONTAINING A HETEROCYCLIC MODULATOR OF ATP-BINDING CASSETTE TRANSPORTERS. VERTEX PHARMA (US) 2014-06-18 EP disclosed
EP-2404919-B1 Heterocyclic compound useful as a modulator of ATP-binding cassette transporters. VERTEX PHARMA (US) 2013-08-21 EP disclosed
EP-2404919-A1 Pharmaceutical composition containing a heterocyclic modulator of ATP-binding cassette transporters. Vertex Pharmaceuticals Incorporated (US) 2012-01-11 EP disclosed